InsidersTradesSigma
에스케이바이오팜 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 에스케이바이오팜 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 에스케이바이오팜 has recorded 3 reports. Market capitalisation: €6,922.9bn. The latest transaction was reported on 31 March 2026 (Sale). Among the most active insiders: SK. Every trade is accessible without an account.
3
Insider Decl.
0
Thresholds
€719m
1 ops.
Buy Volume
·
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 에스케이바이오팜 Buy (bullish), based on 12 analysts. Average price target: ₩136,917.
18Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 5,310 of 26,270 companies
66.7
score / 100
Value40
Quality94
FCF yld2.3%
Earn yld4.2%
EV/EBITDA36.3x
ROE44%
Gross mgn94%
Net mgn38%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 31 March 2026